BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7713469)

  • 21. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
    Sica DA
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):66-71. PubMed ID: 12228845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin converting enzyme inhibitors in perspective: an update.
    Burrell LM; Johnston CI
    Aust Fam Physician; 1993 Jul; 22(7):1243-7, 1251, 1255. PubMed ID: 8373316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AT1-receptor blockers and ACE inhibitors: alternatives or partners?
    Ruilope LM
    Int J Clin Pract Suppl; 2000 Aug; (111):20-4. PubMed ID: 15977403
    [No Abstract]   [Full Text] [Related]  

  • 25. Hypertension: a review with emphasis on therapeutics with ACE inhibitors.
    Preuss HG; Gondal JA; Burris JF
    Md Med J; 1993 Jun; 42(6):557-64. PubMed ID: 8377628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between cyclooxygenase and the renin-angiotensin-aldosterone system: rationale and clinical relevance.
    Meune C; Mourad JJ; Bergmann JF; Spaulding C
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):149-54. PubMed ID: 14608518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Renal side effects of angiotensin converting enzyme inhibitors].
    Schmidt A; Mayer G
    Wien Med Wochenschr; 1996; 146(16):454-6. PubMed ID: 9036683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 29. Angiotensin II type 1 receptor blockade: a novel therapeutic concept.
    Johnston CI
    Blood Press Suppl; 2000; 1():9-13. PubMed ID: 11059629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fixed dose combinations of ACE inhibitors.
    Rangoonwala B; Schulz W; Bauer B
    Br J Clin Pract; 1996 Dec; 50(8):454-65. PubMed ID: 9039718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In arterial hypertension: ACE inhibitors and combination therapy].
    Schrader J; Lüders S
    Pharm Unserer Zeit; 2003; 32(1):46-52. PubMed ID: 12577760
    [No Abstract]   [Full Text] [Related]  

  • 32. Combining aspirin with angiotensin converting enzyme inhibitors in heart failure: how safe is it?
    Mehta H; Mahajan A; Bansal N; Vaidya S; Pathak L
    J Assoc Physicians India; 1998 Nov; 46(11):953-6. PubMed ID: 11229224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drugs as risk factors of food anaphylaxis in adults].
    Moneret-Vautrin DA
    Med Sci (Paris); 2010; 26(8-9):719-23. PubMed ID: 20819708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medications as asthma triggers.
    Covar RA; Macomber BA; Szefler SJ
    Immunol Allergy Clin North Am; 2005 Feb; 25(1):169-90. PubMed ID: 15579370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined aspirin/ACE inhibitor treatment for CHF.
    Olson KL
    Ann Pharmacother; 2001 Dec; 35(12):1653-8. PubMed ID: 11793637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical use of angiotensin-converting enzyme inhibitors in patients with renal impairment.
    Elliott HL
    Blood Press Suppl; 1994; 2():31-4. PubMed ID: 8061843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Deadly drug interactions].
    Kitano F; Terasawa H
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():143-5. PubMed ID: 18074529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.